The powerful pre-treatment effect: Placebo responses in restless legs syndrome trials

European Journal of Neurology

Volumn 19, Issue 10, 2012, Pages 1305-1310

  De la Fuente Fernandez R ^a  

^a Universidad de La Coruña   (Spain)

Author keywords

Clinical trials; Placebo; Placebo effect; Restless legs syndrome

Indexed keywords

PLACEBO; ROTIGOTINE;

ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; HUMAN; MULTICENTER STUDY; PLACEBO EFFECT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME;

ADOLESCENT; ADULT; AGED; BIAS (EPIDEMIOLOGY); DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBO EFFECT; RESEARCH DESIGN; RESTLESS LEGS SYNDROME; TETRAHYDRONAPHTHALENES; THIOPHENES; YOUNG ADULT;

EID: 84866304578     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03719.x     Document Type: Article

References (18)

1. de la Fuente-Fernández R, Schulzer M, Stoessl AJ. The placebo effect in neurological disorders. Lancet Neurol 2002; 1: 85-91.
2. de la Fuente-Fernández R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001; 293: 1164-1166.
3. de la Fuente-Fernández R, Phillips AG, Zamburlini M, et al. Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res 2002; 136: 359-363.
4. de la Fuente-Fernández R. The placebo-reward hypothesis: dopamine and the placebo effect. Parkinsonism Relat Disord 2009; 3: S72-S74.
5. McRae C, Cherin E, Yamazaki TG, et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 2004; 61: 412-420.
6. de la Fuente-Fernández R, Schulzer M, Mak E, Sossi V. Trials of neuroprotective therapies for Parkinson's disease: problems and limitations. Parkinsonism Relat Disord 2010; 16: 365-369.
7. Trenkwalder C, Benes H, Poewe W, et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008; 7: 595-604.
8. Hening WA, Allen RP, Ondo WG, et al. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord 2010; 25: 1675-1683.
9. Fulda S, Wetter TC. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies. Brain 2008; 131: 902-917.
10. Oertel WH, Benes H, Garcia-Borreguero D, et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med 2008; 9: 228-239.
11. Ferini-Strambi L, Aarskog D, Partinen M, et al. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. Sleep Med 2008; 9: 874-881.
12. Jama L, Hirvonen K, Partinen M, et al. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance. Sleep Med 2009; 10: 630-636.
13. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: John Wiley & Sons, Inc., 1986.
14. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell Scientific Publications, 1987.
15. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993; 2: 121-145.
16. O'Doherty J, Dayan P, Schultz J, Deichmann R, Friston K, Dolan RJ. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 2004; 304: 452-454.
17. Trenkwalder C, Stiasny-Kolster K, Kupsch A, Oertel WH, Koester J, Reess J. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord 2006; 21: 1404-1410.
18. Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Int J Clin Pract 2009; 63: 613-623.